Taiwan's Medigen Vaccine Biologics Corp. is accelerating a Phase 3 clinical trial in Paraguay for its COVID-19 vaccine, with the trial expected to produce key safety and efficacy data during the fourth quarter of this year, the company said Wednesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Rain forecast for northern, eastern Taiwan on Thursday
09/10/2026 11:24 AM - Sports
Taiwan routs Singapore to advance at U-18 Asian Baseball Championship
09/10/2026 11:02 AM - Business
U.S. dollar down in Taipei trading
09/10/2026 10:16 AM - Business
Taiwan shares open lower
09/10/2026 09:15 AM - Politics
Lai welcomes new Palau envoy, thanks ally for int'l support
09/09/2026 08:47 PM